The Aurora Funds, Inc. is a venture capital firm based in Cary, North Carolina, with an additional office in Durham. Founded in 1994, the firm specializes in seed and early-stage investments, primarily in healthcare and information technology sectors. In healthcare, it focuses on biotechnology, therapeutics, medical devices, healthcare services, and healthcare information technology. In the information technology sector, its interests include internet infrastructure, software, data communications, semiconductors, and emerging technologies like photonics and nanotechnology. The firm targets investments in companies located in the Southeastern and Mid-Atlantic United States, typically making initial investments ranging from $50,000 to $2.5 million. As companies mature, The Aurora Funds generally invests between $4 million and $8 million across multiple financing rounds, aiming for companies with enterprise values between $2 million and $40 million and EBITDA up to $75 million. The firm prefers to take a lead or co-lead role in investments and secure a board seat in its portfolio companies.
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle. The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.
Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus. Its products include AGS-0031 for metastatic renal cell carcinoma; AGS-0041 for HIV; CD83 soluble protein for transplant rejection/autoimmune disorders; Anti IFN-alpha monoclonal antibody2 for lupus; and regulatory T cell therapy3 for autoimmune disorders. The company was formerly known as MERIX Bioscience, Inc. Argos Therapeutics was founded in 1997 and is based in Durham, North Carolina.
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and commercialization of novel technologies for disease areas where current therapies don't exist, are ineffective or are inadequate. Cardioxyl has developed industry-leading expertise in the chemistry, biology and clinical applications of nitroxyl technology. The company's core nitroxyl platform has generated several pre-clinical and clinical candidates including the company's lead compound, CXL-1020, currently in clinical development for Acute Decompensated Heart Failure, the most common cause of hospitalization for patients older than 65 years of age.
Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus. Its products include AGS-0031 for metastatic renal cell carcinoma; AGS-0041 for HIV; CD83 soluble protein for transplant rejection/autoimmune disorders; Anti IFN-alpha monoclonal antibody2 for lupus; and regulatory T cell therapy3 for autoimmune disorders. The company was formerly known as MERIX Bioscience, Inc. Argos Therapeutics was founded in 1997 and is based in Durham, North Carolina.
Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle. The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.
Digitalsmiths drives video providers' ability to access video archives and offer personalized experiences through comprehensive, accurate, and actionable video metadata. The company's video discovery solutions are independent of content format or destination device, enabling personalized video experiences that are proven to drive more engagement and greater monetization across mobile, broadband, tablet, and TV offerings. Digitalsmiths' customers include today's leading Hollywood studios, broadcasters, distributors, and publishers including Warner Bros., Turner, The CW Network, Paramount, Telepictures, and more. It was founded in 2006 and is based in Durham, North Carolina.
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and commercialization of novel technologies for disease areas where current therapies don't exist, are ineffective or are inadequate. Cardioxyl has developed industry-leading expertise in the chemistry, biology and clinical applications of nitroxyl technology. The company's core nitroxyl platform has generated several pre-clinical and clinical candidates including the company's lead compound, CXL-1020, currently in clinical development for Acute Decompensated Heart Failure, the most common cause of hospitalization for patients older than 65 years of age.
StrikeIron is the leader in Data-as-a-Service (DaaS), delivering data quality and communications solutions via our cloud platform IronCloud. We provide address verification, email verification, phone validation, phone append, SMS text messaging, and sales tax solutions to customers in a variety of markets. Our solutions are delivered as Web services that can be easily integrated into any application or system. Additionally, our solutions are pre-integrated into leading platforms like: Salesforce.com, Magento, Informatica, Oracle CRM On-Demand, and more. Visit us on the web at http://www.strikeiron.com or follow us on Twitter @StrikeIron.
Centice develops PASS Rx, a pharmaceutical authentication sensor system improving the verification process for dispensed medications. Centice has focuses on the development of the PASS Rx system, a pharmaceutical verification product. The company was founded in 2003 and headquartered in Morrisville, North Carolina.
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle. The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.
Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle. The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.
StrikeIron is the leader in Data-as-a-Service (DaaS), delivering data quality and communications solutions via our cloud platform IronCloud. We provide address verification, email verification, phone validation, phone append, SMS text messaging, and sales tax solutions to customers in a variety of markets. Our solutions are delivered as Web services that can be easily integrated into any application or system. Additionally, our solutions are pre-integrated into leading platforms like: Salesforce.com, Magento, Informatica, Oracle CRM On-Demand, and more. Visit us on the web at http://www.strikeiron.com or follow us on Twitter @StrikeIron.
Digitalsmiths drives video providers' ability to access video archives and offer personalized experiences through comprehensive, accurate, and actionable video metadata. The company's video discovery solutions are independent of content format or destination device, enabling personalized video experiences that are proven to drive more engagement and greater monetization across mobile, broadband, tablet, and TV offerings. Digitalsmiths' customers include today's leading Hollywood studios, broadcasters, distributors, and publishers including Warner Bros., Turner, The CW Network, Paramount, Telepictures, and more. It was founded in 2006 and is based in Durham, North Carolina.
Unitrends increases uptime and confidence in a world in which IT professionals must do more with less. Unitrends leverages high-availability hardware and software engineering, cloud economics, enterprise power with consumer-grade design, and customer-obsessed support to natively provide all-in-one enterprise backup and continuity. The result is a “one throat to choke” set of offerings that allow our customers to focus on their business rather than backup.
ALDAGEN is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. We have four product candidates in clinical trials. Our most advanced product candidate is ALD-101. We are currently conducting a pivotal Phase 3 clinical trial of ALD-101 to evaluate its efficacy in improving umbilical cord blood, or cord blood, transplants used to treat inherited metabolic diseases in pediatric patients. We are also conducting or supporting Phase 1 or Phase 1/2 clinical trials of three other product candidates ALD--151 to improve cord blood transplants used for the treatment of leukemia; ALD-301 to treat critical limb ischemia; and ALD-201 to treat ischemic heart failure.
Centice develops PASS Rx, a pharmaceutical authentication sensor system improving the verification process for dispensed medications. Centice has focuses on the development of the PASS Rx system, a pharmaceutical verification product. The company was founded in 2003 and headquartered in Morrisville, North Carolina.
Casenet offers customizable care management software solutions, which allow payers and care coordinators of all sizes to partner with consumers and their physicians in making clinical decisions. Among the software solutions, the company offers packages of case management, disease management, utilization management, and extended enterprise.
Altiris Therapeutics
Series B in 2007
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection. Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia.
Digitalsmiths drives video providers' ability to access video archives and offer personalized experiences through comprehensive, accurate, and actionable video metadata. The company's video discovery solutions are independent of content format or destination device, enabling personalized video experiences that are proven to drive more engagement and greater monetization across mobile, broadband, tablet, and TV offerings. Digitalsmiths' customers include today's leading Hollywood studios, broadcasters, distributors, and publishers including Warner Bros., Turner, The CW Network, Paramount, Telepictures, and more. It was founded in 2006 and is based in Durham, North Carolina.
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
Agility Healthcare Solutions provides a range of RFID-enabled workflow management solutions to the healthcare market. It offers real-time location system technology applications to track the physical location of patients, assets, and staff members for hospitals. The company’s products include AgileTrac Access, a real-time tracking system for healthcare organizations to gain control over their mobile assets; AgileTrac Asset Manager, a real-time tracking system to monitor the usage, status, and location of various mobile assets; and AgileTrac Patient Flow, a solution that gathers input on the movement of patients and assets through the facility and enables hospital staff to direct the flow of care. It also provides AgileTrac Bed Manager, a solution that automates various bed management processes, and tracks patients, staff, and equipment in real-time; AgileTrac ED, an emergency department (ED) solution that enables users to take control of the ED; and AgileTrac Surgical Services that enables users to track and manage the flow of surgical patients and resources. Agility Healthcare Solutions was founded in 2002 and is based in Glen Allen, Virginia.
Recordant, Inc. develops and markets audio-capture technology that empowers organizations to improve sales and customer service by recording, analyzing, and transforming face-to-face conversations between associates and the public into actionable intelligence. It offers archival, analytics, consulting, training, assessments, capture, playback, and forensics solutions in the areas of market research, sales force optimization, compliance, training retention and reinforcement, and risk management. The company also provides personal recording devices, aggregators, desktop aggregators, handset interface devices, microphone interface devices, and USB interface devices, as well as SoundMirror, a Web-based application that ensures access to business recordings and data. Recordant, Inc. serves automotive, retail, government, hospitality, law enforcement, financial services, and higher education markets. The company was founded in 2005 and is headquartered in Alpharetta, Georgia. On February 10, 2009, Recordant, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of Georgia, Atlanta.
ALDAGEN is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. We have four product candidates in clinical trials. Our most advanced product candidate is ALD-101. We are currently conducting a pivotal Phase 3 clinical trial of ALD-101 to evaluate its efficacy in improving umbilical cord blood, or cord blood, transplants used to treat inherited metabolic diseases in pediatric patients. We are also conducting or supporting Phase 1 or Phase 1/2 clinical trials of three other product candidates ALD--151 to improve cord blood transplants used for the treatment of leukemia; ALD-301 to treat critical limb ischemia; and ALD-201 to treat ischemic heart failure.
Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and commercialization of novel technologies for disease areas where current therapies don't exist, are ineffective or are inadequate. Cardioxyl has developed industry-leading expertise in the chemistry, biology and clinical applications of nitroxyl technology. The company's core nitroxyl platform has generated several pre-clinical and clinical candidates including the company's lead compound, CXL-1020, currently in clinical development for Acute Decompensated Heart Failure, the most common cause of hospitalization for patients older than 65 years of age.
Cantex Pharmaceuticals is a biotechnology company engaged in harnessing known therapies to develop novel and safer cancer treatments. Cantex is currently conducting two unique development programs with modified versions of two separate known chemical entities each of which addresses major unmet medical needs representing high-value market opportunities:
Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle. The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.
StrikeIron is the leader in Data-as-a-Service (DaaS), delivering data quality and communications solutions via our cloud platform IronCloud. We provide address verification, email verification, phone validation, phone append, SMS text messaging, and sales tax solutions to customers in a variety of markets. Our solutions are delivered as Web services that can be easily integrated into any application or system. Additionally, our solutions are pre-integrated into leading platforms like: Salesforce.com, Magento, Informatica, Oracle CRM On-Demand, and more. Visit us on the web at http://www.strikeiron.com or follow us on Twitter @StrikeIron.
Cropsolution
Series C in 2005
Cropsolution uses chemistry technology to discover and develop agrochemicals to protect crops from diseases, weeds, and pests.
Synchris (formerly MAP ROI Systems) is a developer of G-Force(TM), the most effective integrated, collaborative, end-to-end web based system for identifying, qualifying, proposing and managing government contracts.
ALN was founded in 2000 in Denver, Colorado. Today, we have over 130 employees in five states and service over 500 physicians and mid-level providers. Our management team is a unique blend of executives from large corporations (Accenture, McKesson), former practice managers, former billing company founders, and professionals in the areas of coding, compliance and healthcare accounting. The average healthcare tenure of the members of ALN’s executive team is almost 20 years.
Nextreme designs and manufactures micro-scale thermal and power management products for the semiconductor, photonics, consumer, automotive and defense/aerospace industries. The company has embedded cooling and power generation capabilities into the widely accepted copper pillar bumping process used in high-volume electronic packaging. Nextreme’s breakthrough addresses the most challenging thermal and power management constraints in electronics today, and delivers the only fully-scalable technology solution by leveraging the existing, high-volume flip chip manufacturing infrastructure. By minimizing the need for manufacturing changes and focusing on developing a seamless design-in solution, Nextreme is changing the future of thermal and power management for the entire electronics industry.
StrikeIron is the leader in Data-as-a-Service (DaaS), delivering data quality and communications solutions via our cloud platform IronCloud. We provide address verification, email verification, phone validation, phone append, SMS text messaging, and sales tax solutions to customers in a variety of markets. Our solutions are delivered as Web services that can be easily integrated into any application or system. Additionally, our solutions are pre-integrated into leading platforms like: Salesforce.com, Magento, Informatica, Oracle CRM On-Demand, and more. Visit us on the web at http://www.strikeiron.com or follow us on Twitter @StrikeIron.
Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers. It develops NTX010, a naturally-occurring virus that attacks and kills neuroendocrine cancers, such as small cell lung cancer, small cell carcinomas originating in other organs, carcinoid, neuroblastoma, and certain other neuroendocrine cancers. The company was founded in 2003 and is headquartered in Malvern, Pennsylvania.
HyperBranch Medical Technology, Inc., a medical device company, develops and markets products primarily for the traumatic or surgically induced wound market. It offers OcuSeal, a liquid ocular bandage for direct application on the surface of the eye to form an ocular bandage, thereby covering an opening in the eye and providing an immediate protective barrier; and Adherus Dural Sealant, which is used as an aid in dural repair in cranial and spinal surgeries, such as the treatment of intracranial aneurysms, tumors, and spinal disc disease. The company also provides Adherus Hernia Mesh Fixation, a device used as a replacement for tacks, staples, sutures, and 'O' rings in hernia repair procedur...
Unitrends increases uptime and confidence in a world in which IT professionals must do more with less. Unitrends leverages high-availability hardware and software engineering, cloud economics, enterprise power with consumer-grade design, and customer-obsessed support to natively provide all-in-one enterprise backup and continuity. The result is a “one throat to choke” set of offerings that allow our customers to focus on their business rather than backup.
Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle. The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.
StrikeIron is the leader in Data-as-a-Service (DaaS), delivering data quality and communications solutions via our cloud platform IronCloud. We provide address verification, email verification, phone validation, phone append, SMS text messaging, and sales tax solutions to customers in a variety of markets. Our solutions are delivered as Web services that can be easily integrated into any application or system. Additionally, our solutions are pre-integrated into leading platforms like: Salesforce.com, Magento, Informatica, Oracle CRM On-Demand, and more. Visit us on the web at http://www.strikeiron.com or follow us on Twitter @StrikeIron.
WideFi Networks, LLC is a technology company with a vision to create a safer internet. Their mission is to create the safest and simplest products that help you protect your family online. WideFi's "Best in Class" cloud-based software SaferNet offers complete online protection and a full-featured online protection system for your family that includes: All devices, Anywhere Protection (Wi-Fi or cellular networks worldwide), Unlimited Schedules and off times, 84 Content filters, GPS Tracking, White or Blacklist Apps & URLs with an on/off toggle, as well as the ability to Monitor everything coming across your network and devices. We also send real-time alerts when someone wanders to risky sites and Unlimited Admins for accountability. All this and more for as little as $7.99 a month.
PsiloQuest
Series B in 2004
PsiloQuest develops and commercializes CMP polishing pads for the semiconductor industry.
Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle. The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.
StemCo Biomedical, Inc. was founded in 1999 and is located in the Research Triangle Park area of NC. The Company is engaged in the development, manufacture and distribution of a series of medical products designed to improve therapeutic transplantation of adult hematopoetic stem and progenitor cells derived from bone marrow, peripheral blood or umbilical cord blood. Addressing a market of more than $1 billion annually, the Company will have a series of products on the market starting in 2002 that identify, sort and custom-engineer stem cell grafts based upon cellular expression of ALDH resulting in what may be better, more effective stem cell transplants in the future.
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
VetCentric, Inc., a privately-held company headquartered near Baltimore, MD, is the only national veterinary-focused pharmacy offering home delivery of FDA- and EPA-approved pharmaceuticals, compounded medications, and therapeutic and wellness diets to pet owners on behalf of veterinary practices. Its comprehensive suite of services provides practices with a customized online store, home delivery and client communications. VetCentric is Vet-VIPPS accredited and firmly supports the Veterinarian-Client-Patient relationship in all its business practices, allowing veterinarians to stay at the center of their patients' care while improving service, encouraging compliance and decreasing practice operating costs.
TriVirix International is a U.S.-based company that manufactures and designs electro-mechanical, medical, diagnostic, analytical, and life-science devices. The company provides its clients with ribo printers, point-of-care blood testing analyzers, volumetric infusion pumps, and vital sign or conscious sedation monitors. TriVirix International is headquartered in Milaca, Minnesota.
PhyFlex Networks
Series B in 2002
PhyFlex Networks is a business services software and broadband access company that creates new business models for cable operators through its True Broadband solution. True Broadband includes a comprehensive software suite for the creation, provisioning, and management of end-to-end broadband services dynamically and on demand.
Cropsolution
Series A in 2002
Cropsolution uses chemistry technology to discover and develop agrochemicals to protect crops from diseases, weeds, and pests.
Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company. Norak is utilizing its proprietary Transfluor technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors.
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
Zambeel,Inc.
Series B in 2001
Zambeel, Inc. is building an enterprise-class storage system to address today’s high-growth data environments, where up to hundreds of terabytes of data need to be stored reliably, managed efficiently, and accessed through high-speed networks.
TriVirix International is a U.S.-based company that manufactures and designs electro-mechanical, medical, diagnostic, analytical, and life-science devices. The company provides its clients with ribo printers, point-of-care blood testing analyzers, volumetric infusion pumps, and vital sign or conscious sedation monitors. TriVirix International is headquartered in Milaca, Minnesota.
StemCo Biomedical, Inc. was founded in 1999 and is located in the Research Triangle Park area of NC. The Company is engaged in the development, manufacture and distribution of a series of medical products designed to improve therapeutic transplantation of adult hematopoetic stem and progenitor cells derived from bone marrow, peripheral blood or umbilical cord blood. Addressing a market of more than $1 billion annually, the Company will have a series of products on the market starting in 2002 that identify, sort and custom-engineer stem cell grafts based upon cellular expression of ALDH resulting in what may be better, more effective stem cell transplants in the future.
Porivo Technologies, Inc. is developing an Internet-enabled distributed computing platform to harness the unused processing power of idle PCs. By aggregating this tremendous underutilized resource, and creating a sizeable network of users, Porivo's software will create a massively parallel meta-computer with incredible processing power.
Alerts.com, Inc.
Series B in 2000
Alerts.com remotely monitors Web sites to deliver personalized, persistent search results via wireless devices, interactive voice, text and email. The Alerts.com system offers both content alerting capabilities and delivery of content directly to wireless devices using SMS or WAP protocols. Offered as a service through our partners and through Alerts.com's own Internet site, users request to be notified when specific Web content - like a news story or a product price - satisfies the user's alert parameters. The Alerts.com system provides business-to-business and business-to-consumer markets with a seamless, diligent infrastructure service that helps build and manage customer relationships by delivering information when and where people need it. The service, by exposing and delivering dynamic content notifications, generates qualified repeat visits to partners' sites and serves an indispensable role in opt-in, affinity-based marketing efforts.
Emageon provides an enterprise-level information technology solution for the clinical analysis and management of digital medical images within health care provider organizations.
Opsware, Inc. is a software company based in Sunnyvale, California which offers products for server and network device provisioning, configuration and management targeted toward enterprise customers. Opsware also has offices in New York City, Seattle, Washington and Cary, North Carolina. The company that was formerly known as Loudcloud was founded on September 9, 1999 (i.e., 9/9/99) as a managed services provider. After selling the operations side of the business to EDS in the summer of 2002, Loudcloud became Opsware and went to market as a technology company, offering the software that had been developed internally to support customer systems via automated server life-cycle management. In December 2003, Opsware acquired asset management systems provider Tangram Enterprise Solutions, and in December 2004 acquired network device configuration management vendor Rendition Networks. In July 2006 Opsware acquired CreekPath to fill out its Data Center Automation (DCA) product offering, by allowing provisioning of storage components as well. Lastly, in March 2007 Opsware acquired Seattle-based iConclude and their run-book automation software, which allowed Opsware to tightly integrate datacenter management duties end-to-end. In July 2007, HP announced that it had agreed to acquire Opsware for $1.6 billion in cash ($14.25 per share), 16x revenues. It is HP's third largest acquisition behind Compaq and Mercury.
Blackboard Inc. is a leading provider of enterprise technology and solutions tailored for the education sector, serving higher education, K-12, corporate, and government organizations. Founded in 1997 and headquartered in Reston, Virginia, the company offers a range of products designed to enhance teaching and learning experiences. Its flagship platform, Blackboard Learn, supports academic objectives, while Blackboard Collaborate facilitates interactive and mobile learning. Blackboard's offerings also include solutions for assignment integrity, data analytics, program assessment, and student support services. Additionally, Blackboard Connect provides a mass notification service to enhance communication within educational institutions. The company's innovative tools aim to improve engagement, accessibility, and institutional performance, impacting millions of students and educators globally.
TriVirix International is a U.S.-based company that manufactures and designs electro-mechanical, medical, diagnostic, analytical, and life-science devices. The company provides its clients with ribo printers, point-of-care blood testing analyzers, volumetric infusion pumps, and vital sign or conscious sedation monitors. TriVirix International is headquartered in Milaca, Minnesota.
TriVirix International is a U.S.-based company that manufactures and designs electro-mechanical, medical, diagnostic, analytical, and life-science devices. The company provides its clients with ribo printers, point-of-care blood testing analyzers, volumetric infusion pumps, and vital sign or conscious sedation monitors. TriVirix International is headquartered in Milaca, Minnesota.
Engenia Software, developer of an XML-based, Web-enabled, out-of-the-box "Intelligent Dashboard" for the computer desktop.
Alerts.com, Inc.
Series A in 1999
Alerts.com remotely monitors Web sites to deliver personalized, persistent search results via wireless devices, interactive voice, text and email. The Alerts.com system offers both content alerting capabilities and delivery of content directly to wireless devices using SMS or WAP protocols. Offered as a service through our partners and through Alerts.com's own Internet site, users request to be notified when specific Web content - like a news story or a product price - satisfies the user's alert parameters. The Alerts.com system provides business-to-business and business-to-consumer markets with a seamless, diligent infrastructure service that helps build and manage customer relationships by delivering information when and where people need it. The service, by exposing and delivering dynamic content notifications, generates qualified repeat visits to partners' sites and serves an indispensable role in opt-in, affinity-based marketing efforts.
Accipiter offers online advertising solutions and services worldwide. It offers AdManager, an ad management solution that allows to increase targeting capabilities to speed ad delivery and to monitor and control inventory projections in real-time; Ad Trafficking, which provides AdManager hosted clients with outsourced and customized solution to administer the campaign management process; AdMarket, a real-time bid-for-placement technology enabling publishers to operate branded online advertising marketplaces and transact with advertisers who are requesting a pay-per-click pricing model; and Visitor Interest Behavioral Engine, a behavioral targeting solution that delivers promotions and content to interested prospects. Accipiter is based in Raleigh, North Carolina with an additional office in London, United Kingdom.
Accipiter offers online advertising solutions and services worldwide. It offers AdManager, an ad management solution that allows to increase targeting capabilities to speed ad delivery and to monitor and control inventory projections in real-time; Ad Trafficking, which provides AdManager hosted clients with outsourced and customized solution to administer the campaign management process; AdMarket, a real-time bid-for-placement technology enabling publishers to operate branded online advertising marketplaces and transact with advertisers who are requesting a pay-per-click pricing model; and Visitor Interest Behavioral Engine, a behavioral targeting solution that delivers promotions and content to interested prospects. Accipiter is based in Raleigh, North Carolina with an additional office in London, United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.